JPH0471051B2 - - Google Patents
Info
- Publication number
- JPH0471051B2 JPH0471051B2 JP58106532A JP10653283A JPH0471051B2 JP H0471051 B2 JPH0471051 B2 JP H0471051B2 JP 58106532 A JP58106532 A JP 58106532A JP 10653283 A JP10653283 A JP 10653283A JP H0471051 B2 JPH0471051 B2 JP H0471051B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- surfactant phase
- cosmetics
- elastin
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 claims description 26
- 239000004094 surface-active agent Substances 0.000 claims description 26
- 102000016942 Elastin Human genes 0.000 claims description 24
- 108010014258 Elastin Proteins 0.000 claims description 24
- 229920002549 elastin Polymers 0.000 claims description 24
- 239000002537 cosmetic Substances 0.000 claims description 16
- 239000000839 emulsion Substances 0.000 claims description 13
- 150000005846 sugar alcohols Polymers 0.000 claims description 11
- 239000003921 oil Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 235000014593 oils and fats Nutrition 0.000 claims description 4
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- 239000012071 phase Substances 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- -1 polyglycerin Chemical compound 0.000 description 12
- 230000001804 emulsifying effect Effects 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 238000004945 emulsification Methods 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 150000003862 amino acid derivatives Chemical class 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 210000003041 ligament Anatomy 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229940071162 caseinate Drugs 0.000 description 2
- 238000010835 comparative analysis Methods 0.000 description 2
- 239000008271 cosmetic emulsion Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- MILWSGRFEGYSGM-UHFFFAOYSA-N propane-1,2-diol;propane-1,2,3-triol Chemical compound CC(O)CO.OCC(O)CO MILWSGRFEGYSGM-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- GGKLADJTQDGVBP-UHFFFAOYSA-M sodium;propane-1,2,3-triol;chloride Chemical compound [Na+].[Cl-].OCC(O)CO GGKLADJTQDGVBP-UHFFFAOYSA-M 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Colloid Chemistry (AREA)
- Cosmetics (AREA)
Description
[産業上の利用分野]
本発明は界面活性剤相中油型の化粧料用乳化組
成物の製造方法に関するものであり、詳しくは、
牛などの動物項靭帯などに存在するエラスチンの
加水分解物を乳化剤として用いた化粧料用乳化組
成物の製造方法に関するものである。
[従来の技術]
従来、化粧料として用いられている界面活性剤
相中油型の乳化組成物としてスパン系、ツイーン
系などの非イオン系界面活性剤、或いは各種アミ
ノ酸の誘導体からなる界面活性剤を用いたものが
知られている。
[発明が解決しようとする課題]
ところが、前記従来の界面活性剤相中油型の化
粧料用乳化組成物は、界面活性作用は充分である
が、安全性および感触が充分でなく、殊に各種ア
ミノ酸の誘導体からなる界面活性剤を用いたもの
では乳化も充分でなく、別途に乳化剤が必要であ
るなどの問題点がある。
本発明は斬る実情に鑑みてなされたものであつ
て、安全性が高く、乳化系がきわめて安定である
とともに、優れた保湿、保水性を有し、感触的に
も優れた界面活性剤相中油型の化粧料用乳化組成
物の製造方法を提供することを目的とする。
[問題点を解決するための手段]
本発明者らは、エラスチン加水分解物が保湿、
保水効果ならびに乳化能に優れているという知見
の基に新規な化粧料用乳化組成物の製造方法を発
明し前記問題点を解決するための手段としたもの
であり、
第1発明は、エラスチン加水分解物またはエラ
スチン加水分解物を含有する水溶液と、多価アル
コールとを混合して界面活性剤相を形成し、この
界面活性剤相に油脂類を加えることを特徴とし、
第2発明は、エラスチン加水分解物またはエラ
スチン加水分解物を含有する水溶液と、多価アル
コールと、グリチルリチンジカリウム塩、カゼイ
ンソーダ、塩化ナトリウム、塩化カリウムの少な
くとも一種からなるイオン性物質0.1〜5重量%
とを混合して界面活性剤相を形成し、この界面活
性剤相に油脂類を加えることを特徴とする。
そして、前記各発明に用いられるエラスチン加
水分解物は、牛などの動物項靭帯に存在するエラ
スチンを蛋白分解酵素を用いて加水分解処理する
ことにより得られたポリペプタイドであり、中で
も平均分子量1万〜10万程度のものが用いられ
る。これは平均分子量1万以下のものは乳化力に
乏しく、平均分子量10万を越えるものはそれ自身
の溶解性が悪くなるためであり、殊に、平均分子
量5万〜10万のものが好適である。
また、エラスチン加水分解物は、乳化組成物の
総重量に対してポリペプタイド総量として0.001
〜10重量%、好ましくは0.1〜5重量%の割合で
配合される。0.001重量%よりも少ないと乳化能
が期待できず、10重量%を越えた場合には乳化能
ならびに保湿、保水効果の向上がみられず無駄と
なつて、経済的に好ましくないためである。
本発明に用いられるエラスチン加水分解物は例
えば次の方法により得ることができる。
例えば新鮮な牛の凍結靭帯1Kgの細砕物に精製
水5を加え、希釈した水酸化ナトリウム溶液を
用いてPH10.5に調整した後1〜2時間煮沸し、遠
心分離機を用いて脱水して残留物に精製水5を
加え、希硫酸を用いてPH2.0に調整した後再度1
〜2時間煮沸し、遠心分離機を用いて脱水した
後、多量の水で洗い洗液のPHを中性とする。次
に、これを2の水に分散させた後ブレンダにて
撹拌し、蛋白分解酵素を加えて60℃の温度で6〜
8時間、部分的に加水分解する。そして、この部
分分解液を1時間煮沸して残存する酵素を失活さ
せた後に不溶物を濾別して最終ポリペプタイド溶
液を得る。
上記の製造方法によつて得られたポリペプタイ
ド溶液中にはポリペプタイド総量として14.0〜
16.0w/v%を含み、また総窒素として2.0〜
2.5w/v%を含む。これをそのまま使用しても
よく、また乾燥粉末化したものを使用することも
できる。
以上のようにして得られたエラスチン加水分解
物は、乳化組成物の総重量に対してポリペプタイ
ド総量として0.001〜10重量%好ましくは0.1〜5
重量%の割合で配合される。配合量が0.001重量
%より少ないと乳化力が余り期待できず、また配
合量が10%を越えると、乳化力ばかりでなく保
湿・保水効果も頭打ちとなり多量に用いるメリツ
トが余りなく、またコスト的にも高くなり経済的
でない。
このようにエラスチン加水分解は単独でも優れ
た乳化能を有しているが、更に多価アルコールま
たはイオン性物質と併用することにより、その乳
化力は格段に向上し、非常に優れた化粧料用乳化
組成物を得ることができる。
前記各発明に用いられる多価アルコールとして
は、分子内に2個以上の水酸基を有するもので、
例えばエチレングリコール、プロピレングリコー
ル、1,3−ブチレングリコール、グリセリン、
ジグリセリン、ポリエチレングリコール、ポリグ
リセリン、ソルビトール、マルチトール、ソルビ
タン、グルコース、フルクトース、シユクロー
ス、マルトースなどが挙げられ、これらの1種ま
たは2種以上の混合物が用いられるが、この中で
も特にグリセリン単独もしくはグリセリンと他の
物質との混合物の場合がより効果的である。
多価アルコールの配合量としては、乳化組成物
の総重量に対して1〜90重量%の範囲が好まし
く、前記範囲内で比較的多量に用いた場合には多
価アルコールを溶解した乳化剤連続相中に油脂類
が分散している界面活性剤相中油型乳化組成物を
得るのに有用である。
また、前記第2発明に用いられるグリチルリチ
ンジカリウム塩、カゼインソーダ、塩化ナトリウ
ム、塩化カリウムなどのイオン性物質は1種また
は2種以上の混合物の形で用いられ、乳化力の向
上及び乳化組成物の安定性向上に寄与する。
イオン性物質は、乳化組成物の総重量に対して
0.1〜5重量%好ましくは0.5〜2重量%の範囲で
配合される。0.1重量%より少ない量では効果が
期待できず、5重量%を越える量を用いても効果
の向上が見られず余り意味がない。
尚、より幅広い乳化組成物を得るため、また乳
化方法の選択幅を広げるため通常用いられる他の
乳化剤、例えばレシチン、しよ糖脂肪酸エステ
ル、ポリグリセリン脂肪酸エステル、その他の非
イオン界面活性剤(HLB3〜14)、脂肪酸塩等の
イオン性界面活性剤等を副活性剤として併用する
ことも可能である。
一方、前記各発明に適用される油脂類としては
特に制限はなく、化粧料に通常用いられる油脂
類、例えば流動パラフイン、セレシン、マイクロ
クリスタリンワツクス等の炭化水素類、オリーブ
油、サフラワー油、ミンク油、牛脂等の動植物
油、ミリスチン酸ミリスチル、オレイン酸オレイ
ル等のエステル類、セタノール、オレイルアルコ
ール等の高級アルコール類、ミリスチン酸、パル
ミチン酸、ステアリン酸等の高級脂肪酸類、及び
香料などが包含され、それぞれの構成比率は系の
外観、使用性、安定性等の目的により任意に選択
される。
本発明の化粧料用乳化組成物の製造方法には、
界面活性剤相乳化法が適用される。即ち、先ずエ
ラスチン加水分解物もしくはこれを含有する水溶
液、多価アルコールおよび必要に応じてイオン性
物質のそれぞれの適量を混合し、これに油相成分
を加えて形成した多価アルコールを溶解したエラ
スチン加水分解物連続相からなる界面活性剤相中
の油相成分を可溶化もしくはマイクロエマルジヨ
ンとして均一分散させることで界面活性剤相中油
型の化粧料用乳化組成物を得る。
しかしながら、前述のような通常用いられる他
の副活性剤を併用した場合には、通常の可溶化反
転法や転相温度乳化法などを利用することも可能
となる。
以上のように本発明の製造方法により得られた
化粧料用乳化組成物は、乳化剤として用いるエラ
スチン加水分解物が高分子量のポリペプタイド物
質であるため安全性が高く、またそれ自身にゲル
形成能があるため多価アルコール効果と相まつて
乳化系がきわめて安定であり、更に優れた保湿・
保水性、皮膜感、感触を兼ね備えたものとなる。
ここで、一般に化粧料として適用されるPH域で
のエラスチン加水分解物自身のPH安定性を表1に
示す。
尚、表1の評価中、「+」は僅かに認める、
「−」は変化のないことを示す。
[Industrial Application Field] The present invention relates to a method for producing an oil-based cosmetic emulsion composition in a surfactant phase.
The present invention relates to a method for producing an emulsified composition for cosmetics using a hydrolyzate of elastin present in the nuchal ligament of animals such as cows as an emulsifier. [Prior Art] Nonionic surfactants such as spanned surfactants and tween surfactants, or surfactants made of various amino acid derivatives, have been used as oil-in-surfactant phase emulsion compositions conventionally used in cosmetics. The one used is known. [Problems to be Solved by the Invention] However, although the conventional surfactant-phase oil-type cosmetic emulsion compositions have sufficient surfactant action, they do not have sufficient safety and feel, and are especially difficult to use when used in various types of cosmetics. If a surfactant made of an amino acid derivative is used, emulsification is not sufficient, and there are problems such as the need for a separate emulsifier. The present invention was made in view of the actual situation of cutting, and is a surfactant phase oil that is highly safe, has an extremely stable emulsion system, has excellent moisturizing and water retention properties, and has an excellent texture. An object of the present invention is to provide a method for producing an emulsified composition for cosmetics. [Means for Solving the Problems] The present inventors have discovered that elastin hydrolyzate has moisturizing and
Based on the knowledge that elastin has excellent water-retaining effect and emulsifying ability, a new method for producing an emulsifying composition for cosmetics has been invented, and it has been used as a means to solve the above-mentioned problems. A second invention is characterized in that an aqueous solution containing a decomposition product or an elastin hydrolyzate and a polyhydric alcohol are mixed to form a surfactant phase, and an oil or fat is added to the surfactant phase. 0.1 to 5% by weight of an ionic substance consisting of an aqueous solution containing a hydrolyzate or elastin hydrolyzate, a polyhydric alcohol, and at least one of glycyrrhizin dipotassium salt, caseinate soda, sodium chloride, and potassium chloride.
The method is characterized in that a surfactant phase is formed by mixing the surfactant and fats and oils are added to the surfactant phase. The elastin hydrolyzate used in each of the above inventions is a polypeptide obtained by hydrolyzing elastin present in the nuchal ligament of animals such as cattle using a proteolytic enzyme, and has an average molecular weight of 10,000 yen. Approximately 100,000 are used. This is because those with an average molecular weight of less than 10,000 have poor emulsifying power, and those with an average molecular weight of more than 100,000 have poor solubility, and those with an average molecular weight of 50,000 to 100,000 are particularly preferred. be. In addition, the elastin hydrolyzate has a total polypeptide content of 0.001 based on the total weight of the emulsified composition.
It is blended in a proportion of ~10% by weight, preferably 0.1~5% by weight. This is because if the amount is less than 0.001% by weight, no emulsifying ability can be expected, and if it exceeds 10% by weight, no improvement in emulsifying ability, moisturizing, or water-retaining effects can be seen and the amount is wasted, which is economically undesirable. The elastin hydrolyzate used in the present invention can be obtained, for example, by the following method. For example, add 5 parts of purified water to 1 kg of crushed fresh frozen cow ligament, adjust the pH to 10.5 using diluted sodium hydroxide solution, boil for 1 to 2 hours, and dehydrate using a centrifuge. Add 5 parts of purified water to the residue, adjust the pH to 2.0 using dilute sulfuric acid, and then add 1 part to the residue again.
After boiling for ~2 hours and dehydrating using a centrifuge, wash with a large amount of water to neutralize the pH of the washing liquid. Next, after dispersing this in water from step 2, stir it in a blender, add proteolytic enzyme, and heat it at 60℃ for 6 to 60 minutes.
Partially hydrolyze for 8 hours. Then, this partially decomposed solution is boiled for 1 hour to inactivate the remaining enzyme, and then insoluble matter is filtered off to obtain the final polypeptide solution. The total amount of polypeptide in the polypeptide solution obtained by the above production method was 14.0 to
Contains 16.0w/v% and 2.0~ as total nitrogen
Contains 2.5w/v%. This may be used as it is, or it may be dried and powdered. The elastin hydrolyzate obtained as described above has a total polypeptide content of 0.001 to 10% by weight, preferably 0.1 to 5% by weight based on the total weight of the emulsified composition.
It is blended in a proportion of % by weight. If the amount is less than 0.001% by weight, you cannot expect much emulsifying power, and if the amount exceeds 10%, not only the emulsifying power but also the moisturizing and water-retaining effects will reach a plateau, and there will be little benefit from using a large amount, and it will also be costly. It is also expensive and uneconomical. In this way, elastin hydrolysis has excellent emulsifying ability when used alone, but when used in combination with polyhydric alcohol or ionic substances, its emulsifying ability is greatly improved, making it an excellent product for use in cosmetics. An emulsified composition can be obtained. The polyhydric alcohol used in each of the above inventions has two or more hydroxyl groups in the molecule,
For example, ethylene glycol, propylene glycol, 1,3-butylene glycol, glycerin,
Examples include diglycerin, polyethylene glycol, polyglycerin, sorbitol, maltitol, sorbitan, glucose, fructose, sucrose, maltose, etc., and one or a mixture of two or more of these can be used, but among these, glycerin alone or glycerin in particular It is more effective when mixed with other substances. The amount of polyhydric alcohol to be blended is preferably in the range of 1 to 90% by weight based on the total weight of the emulsified composition, and when used in a relatively large amount within the above range, the polyhydric alcohol is dissolved in the emulsifier continuous phase. It is useful for obtaining an oil-in-surfactant phase emulsion composition in which fats and oils are dispersed. Furthermore, the ionic substances used in the second invention, such as glycyrrhizin dipotassium salt, caseinate soda, sodium chloride, and potassium chloride, may be used alone or in the form of a mixture of two or more of them to improve the emulsifying power and improve the emulsified composition. Contributes to improved stability. The ionic substance is based on the total weight of the emulsified composition.
It is blended in an amount of 0.1 to 5% by weight, preferably 0.5 to 2% by weight. If the amount is less than 0.1% by weight, no effect can be expected, and if the amount is more than 5% by weight, no improvement in the effect is observed and it is of little use. In addition, in order to obtain a wider range of emulsified compositions and to expand the selection range of emulsification methods, other commonly used emulsifiers such as lecithin, sucrose fatty acid esters, polyglycerin fatty acid esters, and other nonionic surfactants (HLB3 ~14) It is also possible to use an ionic surfactant such as a fatty acid salt as a sub-active agent. On the other hand, the oils and fats applicable to each of the above inventions are not particularly limited, and include oils and fats commonly used in cosmetics, hydrocarbons such as liquid paraffin, ceresin, and microcrystalline wax, olive oil, safflower oil, and mink oil. These include oil, animal and vegetable oils such as beef tallow, esters such as myristyl myristate and oleyl oleate, higher alcohols such as cetanol and oleyl alcohol, higher fatty acids such as myristic acid, palmitic acid, and stearic acid, and fragrances. , the respective composition ratios are arbitrarily selected depending on the objectives such as the appearance, usability, and stability of the system. The method for producing the emulsified composition for cosmetics of the present invention includes:
A surfactant phase emulsification method is applied. That is, first, appropriate amounts of an elastin hydrolyzate or an aqueous solution containing the same, a polyhydric alcohol, and an ionic substance as necessary are mixed, and then an oil phase component is added to form elastin in which the polyhydric alcohol is dissolved. An emulsified composition for cosmetics having an oil-in-surfactant phase is obtained by solubilizing or uniformly dispersing an oil phase component in a surfactant phase consisting of a continuous hydrolyzate phase or as a microemulsion. However, when other commonly used subactivators as mentioned above are used in combination, it becomes possible to use the usual solubilization inversion method, phase inversion temperature emulsification method, etc. As described above, the emulsified composition for cosmetics obtained by the production method of the present invention has high safety because the elastin hydrolyzate used as an emulsifier is a high molecular weight polypeptide substance, and also has gel-forming ability itself. Because of this, combined with the polyhydric alcohol effect, the emulsification system is extremely stable, and it has even better moisturizing properties.
It has a combination of water retention, film feel, and texture. Table 1 shows the PH stability of the elastin hydrolyzate itself in the PH range generally applied as cosmetics. In addition, during the evaluation in Table 1, "+" is slightly accepted.
"-" indicates no change.
【表】
表1によればエラスチン加水分解物が化粧料と
して適用されるPH域できわめて安定であることが
判明した。
次に、本発明により製造された化粧料用乳化組
成物について行つた評価試験の結果を表2および
表3に示す。
表2は後述の実施例1によつて製造された化粧
料用乳化組成物(準非水エマルジヨン)と、実施
例1中のエラスチン加水分解物(含有量1.05重量
%)の代りに従来のノニオン活性剤(ツイーン
60:0.5重量%+スパン60:0.55重量%)を用い
た準非水エマルジヨン(比較例1)およびアミノ
酸誘導体(N−ラウロイルグルタミン酸ポリオキ
シエチレン2モル−2−オクチルドデシルエーテ
ルジエステル:0.5重量%+N−ラウロイルグル
タミン酸ポリオキシエチレン5モルステアリルエ
ーテルジエステル:0.13重量%+ポリオキシエチ
レン付加脂肪族エーテル系SAA:0.42重量%)
を活性剤として用いて準非水エマルジヨン(比較
例2)との各種比較評価試験の結果を示す。
表3は後述の実施例3中のエラスチン加水分解
物(含有量1.05重量%)の代りに従来のノニオン
活性剤(ツイーン60:0.5重量%+スパン60:
0.55重量%)を用いた準非水エマルジヨン(比較
例3)およびアミノ酸誘導体(N−ラウロイルグ
ルタミン酸ポリオキシエチレン2モル−2−オク
チルドデシルエーテルジエステル:0.5重量%+
N−ラウロイルグルタミン酸ポリオキシエチレン
5モルステアリルエーテルジエステル:0.13重量
%+ポリオキシエチレン付加脂肪族エーテル系
SAA:0.42重量%)を活性剤として用いた準非
水エマルジヨン(比較例4)との各種比較評価試
験の結果を示す。
尚、表2および表3中の評価中◎は「優」、○
は「良」、△は「良以下」ならびに×は「悪」を
示す。また、「安全性」については、各20名につ
いて行なつた上腕内側部における48時間クローズ
ドパツチテストの陽性率を判断の基準とし、「安
定性」については各サンプル5個についてエージ
ング試験(−5〜40℃、2ヶ月経時)により判断
し、また、「感触」については各被試験者50名に
よる2週間使用テスト時の官能評価によつた。[Table] According to Table 1, it was found that elastin hydrolyzate is extremely stable in the pH range where it is applied as a cosmetic. Next, Tables 2 and 3 show the results of evaluation tests conducted on the emulsified composition for cosmetics produced according to the present invention. Table 2 shows the emulsified composition for cosmetics (semi-nonaqueous emulsion) produced in Example 1 described later and a conventional nonionic emulsion in place of the elastin hydrolyzate (content 1.05% by weight) in Example 1. Activator (Tween
Semi-nonaqueous emulsion (Comparative Example 1) using N-lauroylglutamate polyoxyethylene 2 mol-2-octyl dodecyl ether diester: 0.5 wt% + N -Lauroylglutamate polyoxyethylene 5 moles stearyl ether diester: 0.13% by weight + polyoxyethylene-added aliphatic ether SAA: 0.42% by weight)
The results of various comparative evaluation tests with semi-nonaqueous emulsion (Comparative Example 2) using as an activator are shown below. Table 3 shows a conventional nonionic active agent (Tween 60: 0.5% by weight + Span 60:
0.55% by weight)) and an amino acid derivative (N-lauroylglutamic acid polyoxyethylene 2 mol-2-octyl dodecyl ether diester: 0.5% by weight +
N-lauroyl glutamic acid polyoxyethylene 5 moles stearyl ether diester: 0.13% by weight + polyoxyethylene addition aliphatic ether system
The results of various comparative evaluation tests with a semi-nonaqueous emulsion (Comparative Example 4) using SAA (0.42% by weight) as an activator are shown. In addition, in the evaluations in Tables 2 and 3, ◎ is "Excellent", ○
indicates "good", △ indicates "below good", and x indicates "bad". Regarding "safety," the criteria for judgment was the positive rate of a 48-hour closed patch test on the inner side of the upper arm conducted on each of 20 people, and for "stability," an aging test (- 5 to 40° C. for 2 months), and "feel" was evaluated by sensory evaluation during a 2-week usage test by 50 test subjects.
【表】【table】
【表】【table】
以下に本発明の実施例を示す。
尚、各実施例における各成分の数値は重量%を
示す。
実施例 1
準非水エマルジヨン
成分Aエラスチン加水分解物15%水溶液
(平均分子量 約90000)
グリセリン
プロピレングリコール7.0
5.0
1.0
成分B 流動パラフイン 40.0
成分C グリセリン 47.0
成分Aを70〜85℃の温度で混合して界面活性剤
相を形成し、これに成分Bを徐々に添加し、次に
成分Cを加えて冷却した。
実施例 2
準非水エマルジヨン
成分Aエラスチン加水分解物15%水溶液
(平均分子量 約50000)
グリセリン
塩化ナトリウム20.0
10.0
0.5
成分Bスクワラン
セタノール30.0
2.0
成分C グリセリン 37.5
成分Aを70〜80℃の温度で混合して界面活性剤
相を形成し、これに成分Bを徐々に添加し、次に
成分Cを加えて冷却した。
実施例 3
準非水エマルジヨン
成分Aエラスチン加水分解物15%水溶液
(平均分子量 約70000)
グリセリン
カゼインソーダ7.0
5.0
1.0
成分B 流動パラフイン70 40.0
成分C グリセリン 47.0
成分Aを70〜85℃の温度で混合して界面活性剤
相を形成し、これに成分Bを徐々に添加し、次に
成分Cを加えて冷却した。
Examples of the present invention are shown below. In addition, the numerical value of each component in each Example shows weight%. Example 1 Semi-non-aqueous emulsion Component A 15% aqueous solution of elastin hydrolyzate (average molecular weight approximately 90,000) Glycerin Propylene glycol 7.0 5.0 1.0 Component B Liquid paraffin 40.0 Component C Glycerin 47.0 Component A was mixed at a temperature of 70 to 85°C. A surfactant phase was formed, to which component B was gradually added, followed by component C and cooled. Example 2 Semi-nonaqueous emulsion Component A 15% aqueous solution of elastin hydrolyzate (average molecular weight approximately 50,000) Glycerin Sodium chloride 20.0 10.0 0.5 Component B Squalanesetanol 30.0 2.0 Component C Glycerin 37.5 Component A was mixed at a temperature of 70 to 80°C. A surfactant phase was formed, to which component B was gradually added, followed by component C, and the mixture was cooled. Example 3 Semi-nonaqueous emulsion Component A 15% aqueous solution of elastin hydrolyzate (average molecular weight approximately 70,000) Glycerin casein soda 7.0 5.0 1.0 Component B Liquid paraffin 70 40.0 Component C Glycerin 47.0 Component A was mixed at a temperature of 70 to 85°C. A surfactant phase was formed, to which component B was gradually added, followed by component C, and the mixture was cooled.
Claims (1)
分解物を含有する水溶液と、多価アルコールとを
混合して界面活性剤相を形成し、この界面活性剤
相に油脂類を加えることを特徴とする界面活性剤
相中油型の化粧料用乳化組成物の製造方法。 2 エラスチン加水分解物またはエラスチン加水
分解物を含有する水溶液と、多価アルコールと、
グリチルリチンジカリウム塩、カゼインソーダ、
塩化ナトリウム、塩化カリウムの少なくとも一種
からなるイオン性物質0.1〜5重量%とを混合し
て界面活性剤相を形成し、この界面活性剤相に油
脂類を加えることを特徴とする界面活性剤相中油
型の化粧料用乳化組成物の製造方法。[Claims] 1. Elastin hydrolyzate or an aqueous solution containing elastin hydrolyzate and polyhydric alcohol are mixed to form a surfactant phase, and oils and fats are added to this surfactant phase. A method for producing a characteristic oil-in-surfactant phase emulsion composition for cosmetics. 2 an elastin hydrolyzate or an aqueous solution containing an elastin hydrolyzate, and a polyhydric alcohol;
Glycyrrhizin dipotassium salt, casein soda,
A surfactant phase characterized by mixing 0.1 to 5% by weight of an ionic substance consisting of at least one of sodium chloride and potassium chloride to form a surfactant phase, and adding oils and fats to this surfactant phase. A method for producing a medium oil type emulsion composition for cosmetics.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58106532A JPS59231007A (en) | 1983-06-14 | 1983-06-14 | Emulsified composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58106532A JPS59231007A (en) | 1983-06-14 | 1983-06-14 | Emulsified composition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4210946A Division JPH0742221B2 (en) | 1992-07-15 | 1992-07-15 | Method for producing emulsified composition for cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59231007A JPS59231007A (en) | 1984-12-25 |
| JPH0471051B2 true JPH0471051B2 (en) | 1992-11-12 |
Family
ID=14435997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58106532A Granted JPS59231007A (en) | 1983-06-14 | 1983-06-14 | Emulsified composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59231007A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2549118B2 (en) * | 1987-05-30 | 1996-10-30 | 三省製薬株式会社 | Emulsified composition |
| JP2004231619A (en) * | 2003-02-03 | 2004-08-19 | Pola Chem Ind Inc | Emulsion composition, emulsion cosmetic containing the same as constituent and method for producing the same |
-
1983
- 1983-06-14 JP JP58106532A patent/JPS59231007A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59231007A (en) | 1984-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3542919A (en) | Astringent alkali metal aluminum complexes of hydroxy acids | |
| JPS6341411A (en) | Dermatic agent for external use | |
| JP2549118B2 (en) | Emulsified composition | |
| JP3667046B2 (en) | Fine emulsion composition | |
| JPS58201708A (en) | Cosmetic composition | |
| JPH0471051B2 (en) | ||
| JPH0520403B2 (en) | ||
| EP0062352A1 (en) | Soap composition | |
| JPH0470940B2 (en) | ||
| JP4228435B2 (en) | Powdered oil and fat composition and method for producing the same | |
| JP2001072581A (en) | Liquid emulsified composition for skin | |
| JP3090725B2 (en) | Production method of powdered fat | |
| JPH0742221B2 (en) | Method for producing emulsified composition for cosmetics | |
| JP2729304B2 (en) | Oil-in-water emulsion composition | |
| JP3927095B2 (en) | Oily foam aerosol composition | |
| US2086479A (en) | Stable emulsion and method of producing the same | |
| US2079166A (en) | Topical preparation | |
| JPH0435212B2 (en) | ||
| JPH05301814A (en) | Cosmetic | |
| JPH0723297B2 (en) | Skin cleanser composition | |
| JP2782373B2 (en) | Dressing using frozen protein gel and method for producing the same | |
| EP0273619A2 (en) | Cosmetic composition | |
| JP3755987B2 (en) | Emulsified composition | |
| JPH0774132B2 (en) | Bacteriostatic composition having surface activity | |
| JP2785080B2 (en) | Bath composition |